The company and a selling stockholder have granted the underwriters a 30-day option to purchase up to an additional 698,333 shares and 66,667 shares, respectively, at the initial public offering price to cover over-allotments, if any.
The company and a selling stockholder have granted the underwriters a 30-day option to purchase up to an additional 698,333 shares and 66,667 shares, respectively, at the initial public offering price to cover over-allotments, if any.